ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 36 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,864,000 | +107.4% | 8,147,650 | +35.7% | 0.84% | +87.9% |
| Q3 2019 | $1,381,000 | +13.8% | 6,003,142 | +21.6% | 0.44% | +51.9% |
| Q2 2019 | $1,214,000 | +644.8% | 4,935,250 | +1352.4% | 0.29% | +565.9% |
| Q1 2019 | $163,000 | +23.5% | 339,796 | 0.0% | 0.04% | -8.3% |
| Q4 2018 | $132,000 | -76.3% | 339,796 | -61.1% | 0.05% | -84.5% |
| Q2 2018 | $558,000 | +42.0% | 872,406 | -18.9% | 0.31% | +30.9% |
| Q1 2018 | $393,000 | -57.0% | 1,076,200 | -32.3% | 0.24% | -50.3% |
| Q3 2017 | $915,000 | -36.6% | 1,590,267 | -3.6% | 0.48% | -43.6% |
| Q4 2016 | $1,443,000 | -33.2% | 1,649,078 | +3.1% | 0.84% | -43.5% |
| Q3 2016 | $2,160,000 | – | 1,600,000 | – | 1.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,590,267 | $915,000 | 0.48% |
| ARMISTICE CAPITAL, LLC | 4,382,000 | $2,520,000 | 0.30% |
| DAFNA Capital Management LLC | 333,000 | $192,000 | 0.12% |
| SABBY MANAGEMENT, LLC | 2,434,103 | $1,400,000 | 0.09% |
| Anson Funds Management LP | 1,024,592 | $589,000 | 0.09% |
| Hartford Financial Management Inc. | 18,000 | $10,000 | 0.01% |
| Summit X, LLC | 11,000 | $7,000 | 0.01% |
| SNS Financial Group, LLC | 18,000 | $10,000 | 0.00% |
| DOWLING & YAHNKE LLC | 22,870 | $13,000 | 0.00% |
| A.R.T. Advisors, LLC | 30,005 | $17,000 | 0.00% |